MAPT and Alzheimer disease: To assess within‐ and between‐group variation in the protein composition of aggregates, we compared proteomic data for tau‐IP samples from caudal hippocampus, analyzed individually for 4 AD vs. 4 age‐matched control (AMC) subjects, 61–85 years of age (Table S1).